Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 78Neoplasm Metastasis 16Neoplasms 9Breast Neoplasms, Male 9Brain Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 5Head and Neck Neoplasms 4Colorectal Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Ovarian Epithelial 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Pancreatic Neoplasms 2Neuroma, Acoustic 2Neurofibromatosis 2 2Inflammatory Breast Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Ductal, Breast 2Salivary Gland Neoplasms 1Recurrence 1Prolactinoma 1Pituitary Neoplasms 1Patient Compliance 1Neuroectodermal Tumors, Primitive 1

Interventions

tanezumab 1siltuximab 1erenumab 1antineoplaston AS 2-1 1antineoplaston A10 1Saline Solution 1Radiosurgery 1Radiation Dose Hypofractionation 1Protons 1Proton Therapy 1Lapatinib 1Hyperspectral Imaging 1HDAC-42 1Bevacizumab 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurilemmoma × Lapatinib × Clear all
NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NYU Langone Health

Phase 2 Completed
21 enrolled 8 charts
CNS

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡